DAXAN touts hydrophilic catheters with CE MDR and FDA 510(k) clearance
Chengdu Daxan Innovative Medical Tech Co., Ltd. says its hydrophilic catheter line carries CE MDR certification and two FDA 510(k) clearances, aiming to simplify sourcing for distributors serving Europe and the U.S. The company also points to low-friction coating data, a 20 million-unit annual capacity, and exports to more than 25 countries.
Why it matters: - DAXAN is positioning its catheter line for buyers that need one supplier with documentation for Europe, the U.S. and Asia-Pacific markets. - The regulatory package includes CE MDR certification, FDA 510(k) clearances, ISO 13485:2016 quality management, China NMPA registration, a Free Sale Certificate and a Certificate of Origin. - The product performance claim centers on a hydrophilic coating with a coefficient of friction as low as 0.02, which could matter to procurement teams comparing comfort and handling data.
What happened: - Chengdu Daxan Innovative Medical Tech Co., Ltd. announced its high-quality hydrophilic catheter line for the global urology device market. - The company is based in Chengdu, Sichuan, China, and says it was established in 2016. - DAXAN says the line has CE marking under EU MDR 2017/745 and two FDA 510(k) clearances: K212567 for the hydrophilic intermittent catheter and K243175 for the TPU intermittent catheter. - DAXAN says FDA Establishment Registration FEI 3023329815 is on record in the public FDA database. - The company says products are distributed in more than 25 countries.
The details: - The CE marking was obtained through the Full Quality Assurance route, which reviews the full quality management system. - ISO 13485:2016 certification supports the CE MDR quality system. - The catheter range covers CH06 to CH24 and includes Nelaton, Tiemann, flexible ball-tip and Duro-Pocket® closed-system configurations. - The size range extends from FR 8 to FR 24 across pediatric female, pediatric male, adult female and adult male use cases. - The products are pre-lubricated and ready to use, with no separate water sachet preparation required. - The catheters are made from medical-grade thermoplastic polyurethane and exclude natural rubber latex, DEHP, DNIP and BPA. - DAXAN says the TPU formulation is biodegradable in natural settings. - Hot-polished side eyelets are part of the manufacturing process. - DAXAN says the coating platform uses a chemically modified PVP base and maintains stable lubricity beyond 24 hours after activation. - The coating platform is supported by patents ZL201610861058.4 and ZL201810063901.3. - The company says the coating combines super-hydrophilic surface activation, low-friction delivery, antimicrobial protection, anti-encrustation resistance and anti-thrombogenic properties. - DAXAN operates a cleanroom facility of more than 6,000 square meters with an integrated testing center on site. - The facility covers extrusion molding, injection molding, punching and complete packaging. - Annual production capacity exceeds 20 million hydrophilic-coated catheters. - The company says it has 9-plus years of R&D and production experience in the hydrophilic intermittent catheter segment. - DAXAN’s product portfolio also includes Foley catheters, DJ ureteral stents, ureteral access sheaths and urology guidewires. - OEM and ODM services cover FR sizes CH06 to CH24, four tip options, PVC or TPU material selection and private-label packaging.
Between the lines: - DAXAN is using regulatory proof and manufacturing scale as the core sales pitch, which is aimed at hospital buyers and distributors that want fewer suppliers to qualify. - The dual FDA clearances separate the company’s two material lines, signaling a strategy built around documentation and market access rather than only product features. - The emphasis on COF data, coating durability and material exclusions suggests the company is targeting procurement checklists that prioritize measurable specifications.
What's next: - DAXAN says importers, distributors and OEM partners can seek product specifications, regulatory documents and customization details through the company’s website. - The company is also promoting its broader urology portfolio to buyers looking for private-label and multi-SKU sourcing.
The bottom line: - DAXAN is trying to sell not just a catheter, but a compliance-ready supply platform for global urology buyers.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Coast To Coast Tribune
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.